The PAH Platform for Deep Phenotyping in Korean Subjects

UnknownOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Pulmonary Arterial HypertensionDeep PhenotypingIdiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial Hypertension
Interventions
DIAGNOSTIC_TEST

Deep phenotyping

Each participating hospitals will be collecting whole blood from each patient, through which DNA, RNA, serum, plasma, and peripheral blood mononuclear cells will be extracted from the buffy coat layer for further multi-omics analysis.

Trial Locations (1)

Unknown

RECRUITING

Department of Cardiovascular Medicine, Gachon University, Gil Medical Center, Incheon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sejong General Hospital

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Saint Vincent's Hospital, Korea

OTHER

collaborator

Seoul National University

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Wonkwang University Hospital

OTHER

collaborator

Chungbuk National University Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Severance Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Chonbuk National University Hospital

OTHER

collaborator

Pusan National University Yangsan Hospital

OTHER

lead

Gachon University Gil Medical Center

OTHER

NCT03933579 - The PAH Platform for Deep Phenotyping in Korean Subjects | Biotech Hunter | Biotech Hunter